Evelo Biosciences, Inc. (EVLO) Social Stream



Evelo Biosciences, Inc. (EVLO): $5.05

0.03 (+0.60%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EVLO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 462

in industry

Evelo Biosciences Inc (EVLO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Evelo Biosciences Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
6 $41.5 $9 $20.9 $5.85 257.26%

The Trend in the Analyst Price Target


EVLO's average price target has moved up $0.57 over the prior 39 weeks.

EVLO reports an average of 68.34% for its upside potential over the past 18 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-08 6 41.5 9 20.90 11.38 83.66%
2021-04-10 3 36.0 11 20.20 10.04 101.2%
2021-02-06 3 36.0 11 20.33 16.99 19.66%
2020-12-07 3 17.0 4 9.00 NA NA%
2020-05-21 4 21.0 6 11.67 NA NA%

EVLO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 5 0 1 0 0 6

The Trend in the Broker Recommendations


Over the past 18 months, EVLO's average broker recommendation rating improved by 0.17.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EVLO as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, Evelo Biosciences Inc's variance in analysts' estimates is lower than 0.98% of them.
  • Evelo Biosciences Inc's upside potential (average analyst target price relative to current price) is higher than 82.81% of stocks in the small market cap category.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Evelo Biosciences Inc's number of analysts covering the stock is higher than 79.4% of them.
  • Evelo Biosciences Inc's average analyst price target is higher than 36.25% of Healthcare stocks.

In the Pharmaceutical Products industry, DARE, AMRN and FBIO are the three stocks most similar to Evelo Biosciences Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for EVLO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 2.147 seconds.